< Back to Jobs

Equity Research Analyst

Elion Investments (MLP)

New York City, NY

Posted August 24

Job Description

Elion Investments (a Millennium Capital fund) is a healthcare-focused hedge fund seeking Equity Research Analysts to support our (public markets focused) Therapeutics team. We seek to invest across a wide range of therapeutic areas and technologies, with companies spanning across the spectrum in terms of stages of development (early clinical to mature large cap conglomerates). Our investment style is based on developing conviction following a deep understanding of the fundamental science combined with an appreciation of financial value of target companies. 

As a Research Analyst, you will perform extensive fundamental research (academic/KOL discussions, literature review, investor forum participation, management meetings, etc.) and analysis of therapeutics companies and their industries/market segments. You will create, maintain, and update detailed financial models, acquire and build on in-depth industry expertise, with a goal of consistently generating investable ideas/themes. You will have substantial responsibility in terms of coverage, with significant room for growth beyond.

Candidates should have strong familiarity with the biopharma industry, preferably gained through prior experience in equity research/investment banking, consulting or direct industry experience.

Desired Skills and Experience:

Key attributes of successful candidates include: critical thinking/problem solving skills, ability to work independently, strong attention to detail, a strong work ethic, and a positive attitude. Optimal candidates will also have the following: 

This position is located in New York, NY

Millennium Management is a global investment management firm founded in 1989 that manages approximately $38.7 billion in assets as of June 1, 2019. We have more than 2,800 employees working across offices in the United States, Europe and Asia.

Over the last 25+ years, our mission has remained constant: to deliver the alternative investment industry’s highest quality returns to our investors, and to maintain a commitment to our principles of integrity, discipline and excellence.

Invite Friends To Join Doc